Cheryl M. Burgess - Cosmetic Dermatology - Springer 2005.pdf - dermatologia(2) - anecia0109

Cheryl M. Burgess (Ed.)

Cosmetic Dermatology

Cheryl M. Burgess (Ed.)

Cosmetic

Dermatology

With 35 Figures and 33 Tables

Cheryl M. Burgess, M.D., F.A.A.D.

2311 M Street

NW Suite 504

Washington, D.C. 20037

USA

Library of Congress Control Number: 2004115994

ISBN 3-540-23064-5 Springer Berlin Heidelberg New York

This work is subject to copyright. All rights are reserved, whether the whole or part of the

material is concerned, specifically the rights of translation, reprinting, reuse of illustrations,

recitation, broadcasting, reproduction on microfilm or in any other way, and storage in data

banks. Duplication of this publication or parts thereof is permitted only under the provisions

of the German Copyright Law of September 9, 1965, in its current version, and permission for

use must always be obtained from Springer. Violations are liable to prosecution under the

German Copyright Law.

Springer is a part of Springer Science+Business Media

springeronline.com

Printed in Germany

The use of general descriptive names, registered names, trademarks, etc. in this publication

does not imply, even in the absence of a specific statement, that such names are exempt

from the relevant protective laws and regulations and therefore free for general use.

Product liability: the publishers cannot guarantee the accuracy of any information about

dosage and application contained in this book. In every individual case the user must check

such information by consulting the relevant literature.

Editor: Marion Philipp

Desk Editor: Irmela Bohn

Production: ProEdit GmbH, 69126 Heidelberg, Germany

Cover: Frido Steinen-Broo, EStudio Calamar, Spain

Typesetting: K. Detzner, 67346 Speyer, Germany

Printed on acid-free paper 21/3150 ML 5 4 3 2 1 0

Preface

Two years ago, this book was merely a concept,

fueled by the clinical needs of a new and young-

er generation seeking cosmetic procedures and a

desire to share my own clinical experiences with

botulinum toxin and soft tissue augmentation.

As the concept evolved, the number of topics did

likewise, expanding the book’s scope. With mul-

tiple topics, additional contributing authors

were recruited. In contemplating the level of

writing effort required, I had to ask myself: “How

will this book differ from existing cosmetic der-

matology textbooks”? Patients’ changing demo-

graphics coupled with technological advance-

ments and new FDA product approvals for der-

matology have created an overwhelming need

for cutting-edge information. This book at-

tempts to fill the information deficit.

Today’s demographics are transforming rap-

idly. Aging is no longer associated with frailty and

impaired ability; growing old no longer means

looking old. While the stigma associated with be-

ing “old” is decreasing, patient demand for cos-

metic enhancements is increasing, particularly in

the younger generation who seek interventions at

the earliest signs of aging. Additionally, by 2050,

the U.S. Census Bureau predicts non-Caucasian

populations will comprise greater than 50% of

the total population. Ethnic, racial, and gender

differences present new challenges and necessi-

tate changes in clinical techniques: practitioners’

skills must accommodate demographic shifts lest

clinical interventions falter.

This book’s eight chapters focus on cutting-

edge approaches to assessment and treatment

of the earliest signs of aging. Topics selected

represent areas where technology and im-

proved understanding of cellular biology have

advanced considerably in the past two decades.

Chapters, although distinct, are unified by sev-

eral important themes:

Newer, noninvasive clinical interventions

and therapeutics offer viable alternatives

for younger patients seeking cosmetic

enhancements. These entry-level proce-

dures often accommodate patients’ clini-

cal needs as well as life styles (e.g., time

away from work).

With changing patient demographics,

matching clinical technique to patients’

unique skin type, tone, and color is cru-

cial. When possible, recommendations

reference the Fitzpatrick rating scale.

Patients seeking cosmetic enhance-

ments have definite expectations, and

patient counseling is imperative. Manag-

ing patient expectations is medically

ethical and essential. Apart from discuss-

ing obvious issues of procedures, contra-

indications, and potential adverse ef-

fects, dermatologists must convey a re-

alistic assessment of predicted outcome

and determine if patients have similar

expectations. Although time-consuming,

informed consent procedures cannot be

short circuited.

Cosmetic dermatology is a field with few

established treatment algorithms. Unlike

other medical specialties where clinical

guidelines are standardized by expert

consensus panels, dermatologists must

evaluate each patient on a case-by-case

basis and strategize accordingly. Detailed

treatment planning must include patient

participation.

Cheryl M. Burgess - Cosmetic Dermatology - Springer 2005.pdf

Plik z chomika:

Inne pliki z tego folderu:

Inne foldery tego chomika: